Theseresults validate sEH/AChE dual inhibition as a promising strategyto alleviate the symptomatology while addressing key underlying mechanismsof AD and make compound 12c a promising candidate withthis innovative mechanism of action.55 This evidence concerns the gene EPHX2 and Alzheimer disease.